63323-886Level 3
Sodium Phosphates (sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous)
**Product type:** Human Prescription Drug
**Active ingredient:** SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
**Strength:** 142; 276 mg/mL; mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Fresenius Kabi USA, LLC
**Marketing category:** ANDA (ANDA209997)
**Pharmacologic class:** Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
GET
/api/v1/systems/ndc_fda/nodes/63323-886Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.